Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Ultrasound | Research

Automated Breast Ultrasound (ABUS)-based radiomics nomogram: an individualized tool for predicting axillary lymph node tumor burden in patients with early breast cancer

Authors: Yu Chen, Yongwei Xie, Bo Li, Hua Shao, Ziyue Na, Qiucheng Wang, Hui Jing

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Objectives

Preoperative evaluation of axillary lymph node (ALN) status is an essential part of deciding the appropriate treatment. According to ACOSOG Z0011 trials, the new goal of the ALN status evaluation is tumor burden (low burden, < 3 positive ALNs; high burden, ≥ 3 positive ALNs), instead of metastasis or non-metastasis.
We aimed to develop a radiomics nomogram integrating clinicopathologic features, ABUS imaging features and radiomics features from ABUS for predicting ALN tumor burden in early breast cancer.

Methods

A total of 310 patients with breast cancer were enrolled. Radiomics score was generated from the ABUS images. Multivariate logistic regression analysis was used to develop the predicting model, we incorporated the radiomics score, ABUS imaging features and clinicopathologic features, and this was presented with a radiomics nomogram. Besides, we separately constructed an ABUS model to analyze the performance of ABUS imaging features in predicting ALN tumor burden. The performance of the models was assessed through discrimination, calibration curve, and decision curve.

Results

The radiomics score, which consisted of 13 selected features, showed moderate discriminative ability (AUC 0.794 and 0.789 in the training and test sets). The ABUS model, comprising diameter, hyperechoic halo, and retraction phenomenon, showed moderate predictive ability (AUC 0.772 and 0.736 in the training and test sets). The ABUS radiomics nomogram, integrating radiomics score with retraction phenomenon and US-reported ALN status, showed an accurate agreement between ALN tumor burden and pathological verification (AUC 0.876 and 0.851 in the training and test sets). The decision curves showed that ABUS radiomics nomogram was clinically useful and more excellent than US-reported ALN status by experienced radiologists.

Conclusions

The ABUS radiomics nomogram, with non-invasive, individualized and precise assessment, may assist clinicians to determine the optimal treatment strategy and avoid overtreatment.
Appendix
Available only for authorised users
Literature
1.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.PubMedCrossRef
2.
Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, Zackrisson S, Senkus E, clinicalguidelines@esmo.org EGCEa. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger. Ann Oncol. 2019;30(8):1194–220.PubMedCrossRef
3.
Maxwell F, de Margerie MC, Bricout M, Cauderlier E, Chapelier M, Albiter M, Bourrier P, Espie M, de Kerviler E, de Bazelaire C. Diagnostic strategy for the assessment of axillary lymph node status in breast cancer. Diagn Interv Imaging. 2015;96(10):1089–101.PubMedCrossRef
4.
Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, et al. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918–26.PubMedPubMedCentralCrossRef
5.
Lyman GH, Somerfield MR, Giuliano AE. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: 2016 American Society of Clinical Oncology Clinical Practice Guideline Update Summary. J Oncol Pract. 2017;13(3):196–8.PubMedCrossRef
6.
Feng Y, Huang R, He Y, Lu A, Fan Z, Fan T, Qi M, Wang X, Cao W, Wang X, et al. Efficacy of physical examination, ultrasound, and ultrasound combined with fine-needle aspiration for axilla staging of primary breast cancer. Breast Cancer Res Treat. 2015;149(3):761–5.PubMedCrossRef
7.
Ahmed M, Jozsa F, Baker R, Rubio IT, Benson J, Douek M. Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients. Breast Cancer Res Treat. 2017;166(2):329–36.PubMedPubMedCentralCrossRef
8.
Raber BM, Lin H, Shen Y, Shaitelman SF, Bedrosian I. Trends in Regional Nodal Management of Breast Cancer Patients with Low Nodal Burden. Ann Surg Oncol. 2019;26(13):4346–54.PubMedCrossRef
9.
Ahmed M, Douek M. Is axillary ultrasound imaging necessary for all patients with breast cancer? Br J Surg. 2018;105(8):930–2.PubMedCrossRef
10.
Vourtsis A. Three-dimensional automated breast ultrasound: Technical aspects and first results. Diagn Interv Imaging. 2019;100(10):579–92.PubMedCrossRef
11.
Zhang X, Lin X, Tan Y, Zhu Y, Wang H, Feng R, Tang G, Zhou X, Li A, Qiao Y. A multicenter hospital-based diagnosis study of automated breast ultrasound system in detecting breast cancer among Chinese women. Chin J Cancer Res. 2018;30(2):231–9.PubMedPubMedCentralCrossRef
12.
Wang Q, Li B, Liu Z, Shang H, Jing H, Shao H, Chen K, Liang X, Cheng W. Prediction model of axillary lymph node status using automated breast ultrasound (ABUS) and ki-67 status in early-stage breast cancer. BMC Cancer. 2022;22(1):929.PubMedPubMedCentralCrossRef
13.
Lin X, Wang J, Han F, Fu J, Li A. Analysis of eighty-one cases with breast lesions using automated breast volume scanner and comparison with handheld ultrasound. Eur J Radiol. 2012;81(5):873–8.PubMedCrossRef
14.
van Zelst JCM, Mann RM. Automated Three-dimensional Breast US for Screening: Technique, Artifacts, and Lesion Characterization. Radiographics. 2018;38(3):663–83.PubMedCrossRef
15.
Zheng FY, Yan LX, Huang BJ, Xia HS, Wang X, Lu Q, Li CX, Wang WP. Comparison of retraction phenomenon and BI-RADS-US descriptors in differentiating benign and malignant breast masses using an automated breast volume scanner. Eur J Radiol. 2015;84(11):2123–9.PubMedCrossRef
16.
Luo WQ, Huang QX, Huang XW, Hu HT, Zeng FQ, Wang W. Predicting Breast Cancer in Breast Imaging Reporting and Data System (BI-RADS) Ultrasound Category 4 or 5 Lesions: A Nomogram Combining Radiomics and BI-RADS. Sci Rep. 2019;9(1):11921.PubMedPubMedCentralCrossRef
17.
Yu FH, Wang JX, Ye XH, Deng J, Hang J, Yang B. Ultrasound-based radiomics nomogram: A potential biomarker to predict axillary lymph node metastasis in early-stage invasive breast cancer. Eur J Radiol. 2019;119:108658.PubMedCrossRef
18.
Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, Ma ZL, Liu ZY. Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer. J Clin Oncol. 2016;34(18):2157–64.PubMedCrossRef
19.
Yang M, Liu H, Dai Q, Yao L, Zhang S, Wang Z, Li J, Duan Q. Treatment Response Prediction Using Ultrasound-Based Pre-, Post-Early, and Delta Radiomics in Neoadjuvant Chemotherapy in Breast Cancer. Front Oncol. 2022;12:748008.PubMedPubMedCentralCrossRef
20.
Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue R, Even AJG, Jochems A, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749–62.PubMedCrossRef
21.
Koelliker SL, Chung MA, Mainiero MB, Steinhoff MM, Cady B. Axillary lymph nodes: US-guided fine-needle aspiration for initial staging of breast cancer–correlation with primary tumor size. Radiology. 2008;246(1):81–9.PubMedCrossRef
22.
Zwanenburg A, Vallieres M, Abdalah MA, Aerts H, Andrearczyk V, Apte A, Ashrafinia S, Bakas S, Beukinga RJ, Boellaard R, et al. The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. Radiology. 2020;295(2):328–38.PubMedCrossRef
23.
Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15(2):155–63.PubMedPubMedCentralCrossRef
24.
Van Zelst JC, Platel B, Karssemeijer N, Mann RM. Multiplanar Reconstructions of 3D Automated Breast Ultrasound Improve Lesion Differentiation by Radiologists. Acad Radiol. 2015;22(12):1489–96.PubMedCrossRef
25.
Wang X, Huo L, He Y, Fan Z, Wang T, Xie Y, Li J, Ouyang T. Early prediction of pathological outcomes to neoadjuvant chemotherapy in breast cancer patients using automated breast ultrasound. Chin J Cancer Res. 2016;28(5):478–85.PubMedPubMedCentralCrossRef
26.
D’Angelo A, Rinaldi P, Belli P, D’Amico R, Carlino G, Grippo C, Giuliani M, Orlandi A, Infante A, Manfredi R. Usefulness of automated breast volume scanner (ABVS) for monitoring tumor response to neoadjuvant treatment in breast cancer patients: preliminary results. Eur Rev Med Pharmacol Sci. 2019;23(1):225–31.
27.
Guldogan N, Yilmaz E, Arslan A, Kucukkaya F, Atila N, Aribal E. Comparison of 3D-Automated Breast Ultrasound With Handheld Breast Ultrasound Regarding Detection and BI-RADS Characterization of Lesions in Dense Breasts: A Study of 592 Cases. Acad Radiol. 2022;29(8):1143–48.
28.
Zhang L, Bao LY, Tan YJ, Zhu LQ, Xu XJ, Zhu QQ, Shan YN, Zhao J, Xie LS, Liu J. Diagnostic Performance Using Automated Breast Ultrasound System for Breast Cancer in Chinese Women Aged 40 Years or Older: A Comparative Study. Ultrasound Med Biol. 2019;45(12):3137–44.PubMedCrossRef
29.
Vourtsis A, Kachulis A. The performance of 3D ABUS versus HHUS in the visualisation and BI-RADS characterisation of breast lesions in a large cohort of 1,886 women. Eur Radiol. 2018;28(2):592–601.PubMedCrossRef
30.
Choi WJ, Kim SH, Shin HJ, Bang M, Kang BJ, Lee SH, Chang JM, Moon WK, Bae K, Kim HH. Automated breast US as the primary screening test for breast cancer among East Asian women aged 40–49 years: a multicenter prospective study. Eur Radiol. 2021;31(10):7771–82.PubMedCrossRef
31.
Yang S, Gao X, Liu L, Shu R, Yan J, Zhang G, Xiao Y, Ju Y, Zhao N, Song H. Performance and Reading Time of Automated Breast US with or without Computer-aided Detection. Radiology. 2019;292(3):540–9.PubMedCrossRef
32.
Zhao F, Cai C, Liu M, Xiao J. Identification of the lymph node metastasis-related automated breast volume scanning features for predicting axillary lymph node tumor burden of invasive breast cancer via a clinical prediction model. Front Endocrinol (Lausanne). 2022;13:881761.PubMedCrossRef
33.
34.
Kotsianos-Hermle D, Hiltawsky KM, Wirth S, Fischer T, Friese K, Reiser M. Analysis of 107 breast lesions with automated 3D ultrasound and comparison with mammography and manual ultrasound. Eur J Radiol. 2009;71(1):109–15.PubMedCrossRef
35.
Zheng FY, Lu Q, Huang BJ, Xia HS, Yan LX, Wang X, Yuan W, Wang WP. Imaging features of automated breast volume scanner: Correlation with molecular subtypes of breast cancer. Eur J Radiol. 2017;86:267–75.PubMedCrossRef
36.
Jiang J, Chen YQ, Xu YZ, Chen ML, Zhu YK, Guan WB, Wang XJ. Correlation between three-dimensional ultrasound features and pathological prognostic factors in breast cancer. Eur Radiol. 2014;24(6):1186–96.PubMedCrossRef
37.
Tang G, An X, Xiang H, Liu L, Li A, Lin X. Automated Breast Ultrasound: Interobserver Agreement, Diagnostic Value, and Associated Clinical Factors of Coronal-Plane Image Features. Korean J Radiol. 2020;21(5):550–60.PubMedPubMedCentralCrossRef
38.
Chen L, Chen Y, Diao XH, Fang L, Pang Y, Cheng AQ, Li WP, Wang Y. Comparative study of automated breast 3-D ultrasound and handheld B-mode ultrasound for differentiation of benign and malignant breast masses. Ultrasound Med Biol. 2013;39(10):1735–42.PubMedCrossRef
39.
Kalmantis K, Dimitrakakis C, Koumpis C, Tsigginou A, Papantoniou N, Mesogitis S, Antsaklis A. The contribution of three-dimensional power Doppler imaging in the preoperative assessment of breast tumors: a preliminary report. Obstet Gynecol Int. 2009;2009:530579.PubMedPubMedCentralCrossRef
40.
Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures. They Are Data Radiology. 2016;278(2):563–77.PubMed
41.
Qiu X, Jiang Y, Zhao Q, Yan C, Huang M, Jiang T. Could Ultrasound-Based Radiomics Noninvasively Predict Axillary Lymph Node Metastasis in Breast Cancer? J Ultrasound Med. 2020;39(10):1897–905.PubMedPubMedCentralCrossRef
42.
Gao Y, Luo Y, Zhao C, Xiao M, Ma L, Li W, Qin J, Zhu Q, Jiang Y. Nomogram based on radiomics analysis of primary breast cancer ultrasound images: prediction of axillary lymph node tumor burden in patients. Eur Radiol. 2021;31(2):928–37.PubMedCrossRef
43.
Jiang M, Li CL, Luo XM, Chuan ZR, Chen RX, Tang SC, Lv WZ, Cui XW, Dietrich CF. Radiomics model based on shear-wave elastography in the assessment of axillary lymph node status in early-stage breast cancer. Eur Radiol. 2022;32(4):2313–25.
44.
Li B, Zhao X, Wang Q, Jing H, Shao H, Zhang L, Cheng W. Prediction of high nodal burden in invasive breast cancer by quantitative shear wave elastography. Quant Imaging Med Surg. 2022;12(2):1336–47.PubMedPubMedCentralCrossRef
45.
Zhou LQ, Wu XL, Huang SY, Wu GG, Ye HR, Wei Q, Bao LY, Deng YB, Li XR, Cui XW, et al. Lymph Node Metastasis Prediction from Primary Breast Cancer US Images Using Deep Learning. Radiology. 2020;294(1):19–28.PubMedCrossRef
46.
Afshar P, Mohammadi A, Plataniotis KN, Oikonomou A, Benali H. From handcrafted to deep-learning-based cancer radiomics: challenges and opportunities. ISPM. 2019;36(4):132–60.
47.
Guo Y, Hu Y, Qiao M, Wang Y, Yu J, Li J, Chang C. Radiomics Analysis on Ultrasound for Prediction of Biologic Behavior in Breast Invasive Ductal Carcinoma. Clin Breast Cancer. 2018;18(3):e335–44.PubMedCrossRef
Metadata
Title
Automated Breast Ultrasound (ABUS)-based radiomics nomogram: an individualized tool for predicting axillary lymph node tumor burden in patients with early breast cancer
Authors
Yu Chen
Yongwei Xie
Bo Li
Hua Shao
Ziyue Na
Qiucheng Wang
Hui Jing
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-10743-3

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue

Research

Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction

Research

Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy

Research

Interaction between PD-L1 and soluble VEGFR1 in glioblastoma-educated macrophages

Research

Prognostic value of CYFRA 21 − 1 and Ki67 in advanced NSCLC patients with wild-type EGFR

Research

Eta polycaprolactone (ε-PCL) implants appear to cause a partial differentiation of breast cancer lung metastasis in a murine model

Research

Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits